USCAP 2023 Contemporary Issues in Breast Pathology

 This course will provide a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant lesions of the breast identified in surgical specimens and core needle biopsies. The most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions and to guide patient management will be emphasized. This course includes a combination of lectures, interactive microscopy sessions, and a panel Q&A.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Describe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies
• Discuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis
• Discuss prognostic and predictive assays in patients with breast cancer

Program : 

– Lobular, Mucinous, and Fibroepithelial Lesions – Laura C. Collins, MD

– Lumpectomy Margin Evaluation, Lesions, and Salivary Gland-like Tumors of the Breast – Stuart J. Schnitt, MD

– Papillary Lesions, Spindle Cell Lesions, and Uncommon Breast Cancers – Kimberly H. Allison, MD

– Neoadjuvant Chemotherapy, Vascular Lesions, and Intraductal Proliferative Lesions – Gregory R. Bean, MD, PhD

– Ductal, Nipple, Inflammatory, and Reactive Lesions – Edi Brogi, MD, PhD

– Small Glandular Proliferations, Fibroepithelial Lesions, and ER, PR, and HER2 Testing – Ashley M. Cimino-Mathews, MD

– Hot and Controversial Topics in Breast Pathology

– Q&A Panel Discussions

Original release date: July 8, 2023